Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro
N. Mehta et al., Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro, CLIN EXP M, 16(7), 1998, pp. 587-594
Tumor cell arrest and tumor migration are two of the critical steps in the
metastatic cascade. We hypothesized that these steps may be facilitated by
the low density lipoprotein (LDL)-induced activation of microvessel endothe
lial cells (MVEC), The purpose of our study was to investigate the biologic
al effects of an LDL-enriched milieu and the effects of the anticholesterol
drug Lovastatin on metastatic behavior. The SW480 and SW620 are primary an
d metastatic human colonic adenocarcinoma cell lines derived from the same
patient. We investigated the effect of LDL on adhesion and migration of the
two tumor cell lines across human brain, lung, liver and dermal endothelia
l monolayers, Adhesion and migration assays were done before and after pret
reatment of the MVEC or tumor cells with LDL (100 mu g/ml) for 24 h, Althou
gh metastatic SW620 cells were more adherent to MVEC compared with primary
SW480 cells, LDL pretreatment of SW480 and SW620 cells did not affect tumor
cell adhesion to MVEC, In contrast, tumor cell migration was significantly
increased across endothelial monolayers when MVEC were pretreated with LDL
, Transendothelial cell migration was not significantly affected by pretrea
tment of the tumor cells with LDL, Lovastatin is an inhibitor of HMG-CoA re
ductase, the rate-limiting enzyme in cholesterol biosynthesis. It has been
shown to have anti-tumor activity in vitro. We investigated the effect of L
ovastatin on tumor cell kinetics and tumor cell migration across MVEC, Grow
th curves and migration assays were done before and after pretreatment of t
he tumor cells with Lovastatin (30 mu g/ml). Migration assays were also don
e after treatment of unstimulated or LDL-stimulated MVEC (100 mu g/ml) for
24 h with Lovastatin, Lovastatin inhibited the in vitro growth of the metas
tatic SW620 cell line to a greater extent than the invasive SW480E cell lin
e. On the other hand, pretreatment of tumor cells with Lovastatin (30 mu g/
ml) did not suppress transendothelial tumor cell migration of tumor cells,
Finally, Lovastatin given to mice effectively suppressed the number of MCA-
26 tumor colonies in the liver of Balb/c mice compared with untreated mice.